샘플 요청 목록

 카트 문의
시장보고서
상품코드
1798192

세계의 병리 기기 시장

Pathology Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 379 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 병리 기기 시장은 2030년까지 81억 달러에 이를 전망

2024년에 60억 달러로 추정되는 병리 기기 세계 시장은 2024-2030년 분석 기간에 CAGR 5.1%로 성장하여 2030년에는 81억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 임상화학 기술은 CAGR 6.0%를 나타내고, 분석 기간 종료시에는 33억 달러에 이를 것으로 예측됩니다. 면역측정 기술 분야의 성장률은 분석 기간중 CAGR 5.7%로 추정됩니다.

미국 시장은 16억 달러로 추정, 중국은 CAGR 9.3%로 성장 예측

미국의 병리 기기 시장은 2024년에 16억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 17억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 9.3%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 2.1%와 4.0%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 3.0%를 보일 전망입니다.

세계의 병리 기기 시장 - 주요 동향과 촉진요인 정리

정밀 진단 수요에 대응하기 위해 병리 기기는 어떻게 발전하고 있는가?

병리 기기는 의료 진단 생태계의 최전선에 위치하며 질병 감지, 분류, 치료 모니터링의 중추 역할을 하고 있습니다. 정밀의료, 최소침습 진단, 조기 질병 확인으로의 전환은 병리조직검사 장비, 세포진단 시스템, 면역조직화학 플랫폼, 디지털 병리 스캐너, 자동 슬라이드 프로세서 등 다양한 병리검사 장비에 혁신을 불러일으키고 있습니다. 이러한 툴은 높은 처리량, 재현성, 분석 민감도가 높은 검사 워크플로우를 구현하는 데 필수적인 역할을 합니다.

병리조직학적 검사는 암 진단 및 병기 결정에 있어 가장 중요한 검사로, 자동 조직 프로세서, 마이크로톰, 임베딩 센터, 염색 시스템에 대한 수요는 그 어느 때보다 중요해지고 있습니다. 액상세포진단(LBC) 시스템, 자동 슬라이드 제작 장치 등의 세포진단 장비는 특히 자궁경부암과 호흡기암을 대상으로 하는 암 검진 프로그램으로 인기를 끌고 있습니다. 한편, 면역조직화학(IHC)은 종양학에서 바이오마커 검출을 위해 크게 채택되고 있으며, 항체 기반 염색 시스템은 일관성과 확장성을 위해 실험실의 자동화 체인에 통합되어 있습니다.

또한, 디지털 파스퇴르의 등장은 슬라이드 기반 진단을 아날로그에서 영상 중심의 플랫폼으로 변화시키고 있습니다. 홀슬라이드 이미징(WSI) 장비는 기존의 유리 슬라이드를 고해상도 디지털 포맷으로 변환하고, 이를 AI가 탑재된 소프트웨어로 분석하여 세포 형태, 종양 등급, 이상 징후를 감지합니다. 이러한 디지털화를 통해 병리학자 간 원격 협업이 가능해져 관찰자 간 편차가 줄어들고, 의료서비스가 부족한 지방의 원격 병리 진단을 지원할 수 있습니다. 병원이 통합 의료 시스템에 통합됨에 따라 병리 검사 장비의 상호 운용성과 중앙 집중식 진단에 대한 수요는 지속적으로 증가하고 있습니다.

기존 병리 워크플로우를 파괴하는 기술 혁신이란?

디지털 전환은 기존의 워크플로우에 이미징, 분석, 클라우드 인프라를 통합하여 병리검사 장비의 상황을 재정의하고 있습니다. 40배 배율로 이미지를 촬영할 수 있는 홀 슬라이드 스캐너는 고속 오토포커스, 깊이 해상도를 위한 Z 스태킹, 대량의 샘플에 대응하는 배치 스캔 기능을 탑재하고 있습니다. 이러한 장비는 AI/ML 알고리즘으로 보완되어 조직의 특징을 정량화하고, 잠재적 이상 징후를 표시하고, 자동 진단 제안을 생성하는 등 병리학자의 의사결정 과정을 간소화합니다.

자동화는 또 다른 중요한 디스럽터(disruptor)입니다. 시약과 프로토콜을 자동으로 선택하는 스마트 염색 플랫폼에 이르기까지 병리검사실은 수작업 개입을 최소화하여 소요시간과 오류율을 줄이고 있습니다. 모듈식 실험실 자동화 시스템은 현재 시료 추적, 바코드 리더기, 액체 처리기, 슬라이드 커버 슬리퍼를 원활한 진단 파이프라인에 연결하여 실험실에서 진단 정확도를 떨어뜨리지 않고 더 빠른 처리량을 달성할 수 있게 해줍니다. 임상검사정보시스템(LIS)과의 통합을 통해 실시간 추적, 컴플라이언스, 보고의 효율성을 더욱 확실하게 보장합니다.

또한, 동반진단약의 등장은 기기 개발에도 영향을 미치고 있습니다. 제약회사와 진단약 제조업체가 협력하여 조직 기반 바이오마커 검증을 지원하는 병리학적 플랫폼을 구축하여 표적 치료 및 개인 맞춤형 종양 치료를 가능하게 하고 있습니다. 멀티플렉스 IHC 및 ISH(in situ hybridization) 도구는 실험실에서 한 장의 슬라이드에서 여러 바이오마커를 검출할 수 있도록 도와주어 조직 샘플을 절약하면서 진단 수율을 높이고 있습니다. 또한, 이러한 기술들은 FDA 및 CE 마킹 프레임워크에서 규제 준수 검증이 이루어지고 있으며, 전 세계적으로 임상 전개가 가능합니다.

병리 기기 수요를 주도하는 최종 사용자와 지역 시장은?

병리 기기의 주요 최종 사용자는 병원, 진단 기준 검사실, 학술 의료 센터, 암 연구 기관입니다. 대형 병원 체인에서는 생검량 증가에 대응하고, 보고서 작성 기간을 단축하고, 병리 인력을 최적화하기 위해 자동 병리 검사 플랫폼의 도입이 빠르게 진행되고 있습니다. 여러 의료 서비스 제공업체의 검사를 처리하는 중앙 검사실은 효율성을 높이고 원격 진료를 가능하게 하기 위해 로봇과 디지털 병리 솔루션에 대한 투자를 늘리고 있습니다.

학술기관과 암센터는 특히 AI 판독과 다중 면역조직화학을 포함한 차세대 장비의 조기 도입에 있어 중요한 역할을 하고 있습니다. 이들 센터는 신기술의 검증 허브 역할을 하며, 임상 및 규제 당국의 승인에 필요한 증거 기반에 기여하는 경우가 많습니다. 또한, 제약사 연구개발 및 의약품 개발 수탁기관(CRO)은 바이오마커 스크리닝 및 약효시험에 디지털 병리 플랫폼을 도입하여 비임상 시장의 성장을 가져오고 있습니다.

지역별로는 북미와 서유럽이 높은 수준의 의료 인프라, 많은 생검량, 병리학적 진단에 대한 지원금 지급으로 인해 여전히 우위를 점하고 있습니다. 특히 미국에서는 CMS의 정책과 FDA의 디지털 영상 가이드라인이 호평을 받으며 병리검사실의 통합과 디지털 병리검사의 보급이 진행되고 있습니다. 한편, 중국, 인도, 한국을 필두로 한 아시아태평양에서는 암 검진 프로그램 확대와 민관 진단 체인의 사업 확대로 병리 인프라가 빠르게 성장하고 있습니다. 라틴아메리카와 중동은 3차 의료와 암 진단에 대한 투자가 장비 도입의 새로운 길을 열고 있는 신흥 시장입니다.

병리 기기 세계 시장의 성장을 가속하는 요인은 무엇인가?

세계 병리 기기 시장의 성장은 만성 및 종양 질환의 유병률 증가, 조기 및 정확한 진단에 대한 수요, 디지털 병리학 및 실험실 자동화의 발전, 개인 맞춤형 의료를 향한 세계 추진력에 의해 주도되고 있습니다. 암 발병률 증가, 인구의 고령화, 예방 의료에 대한 인식이 높아짐에 따라 진단 시스템에는 신속하고 재현성이 높으며 실용적인 결과가 요구되고 있으며, 이는 첨단 병리 기기에 대한 수요를 촉진하고 있습니다.

세계 의료 시스템은 중앙 집중식 디지털 병리학 플랫폼을 채택하여 숙련된 병리학자 부족을 해결하고, 검체에서 보고까지의 시간을 단축하고, 진단의 질을 향상시키고 있습니다. 이와 함께 병리학과 분자진단 및 AI 분석의 통합이 진행되면서 임상의가 조직 샘플에서 더 깊은 통찰력을 얻을 수 있게 되어 개인화된 치료 계획으로 가는 길이 열리고 있습니다. 이러한 요소들은 특히 치료 효과가 정확한 종양 분류와 바이오마커의 상태에 따라 좌우되는 경우가 많은 종양학 분야와 관련이 있습니다.

또한 의료기기 기업, 벤처캐피털, 헬스케어 IT 기업의 강력한 투자가 기술 혁신과 상용화를 가속화하고 있습니다. 진단 실험실, 하이테크 기업, 제약사 간의 공동 개발로 차세대 헬스케어에 적합한 솔루션을 만들어 내고 있습니다. 디지털 병리 기기 승인 및 유연한 임상시험 요건과 같은 규제 발전으로 인해 진입 장벽이 더욱 낮아지고 있습니다. 디지털 의료와 정밀의료가 융합되는 가운데 병리 기기는 현대 진단에 필수 불가결한 존재가 되어 세계 시장의 강력하고 지속적인 확장을 견인할 것입니다.

부문

기술(임상화학, 면역측정, 미생물학, 분자진단, 기타 기술), 용도(Drug Discovery & Development, 질병 진단, 법의학 진단, 기타 용도), 최종사용자(제약 기업, 병원 및 진단실험실, 기타 최종사용자)

조사 대상 기업 예

  • 3DHISTECH
  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter(Danaher)
  • Becton, Dickinson and Company(BD)
  • Bio-Rad Laboratories
  • CellaVision
  • ContextVision
  • Danaher Corporation
  • Epredia(3D HISTECH)
  • F. Hoffmann-La Roche AG
  • Hamamatsu Photonics
  • Hamamatsu Photonics
  • Leica Biosystems(Danaher)
  • Mikroscan Technologies
  • Olympus Corporation
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • PHC Holdings/Sakura Finetek
  • Philips(Digital Pathology)

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.09.03

Global Pathology Devices Market to Reach US$8.1 Billion by 2030

The global market for Pathology Devices estimated at US$6.0 Billion in the year 2024, is expected to reach US$8.1 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Clinical Chemistry Technology, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Immunoassays Technology segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 9.3% CAGR

The Pathology Devices market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Pathology Devices Market - Key Trends & Drivers Summarized

How Are Pathology Devices Advancing to Meet the Demands of Precision Diagnostics?

Pathology devices are at the forefront of the medical diagnostics ecosystem, serving as the backbone of disease detection, classification, and therapeutic monitoring. The shift toward precision medicine, minimally invasive diagnostics, and early disease identification is driving innovation across a range of pathology instrumentation, including histopathology equipment, cytology systems, immunohistochemistry platforms, digital pathology scanners, and automated slide processors. These tools play an indispensable role in enabling high-throughput, reproducible, and analytically sensitive laboratory workflows.

Histopathological examination remains the gold standard in cancer diagnostics and disease staging, making the demand for automated tissue processors, microtomes, embedding centers, and staining systems more critical than ever. Cytology devices, including liquid-based cytology (LBC) systems and automated slide preparers, are gaining traction in cancer screening programs, particularly for cervical and respiratory tract cancers. Immunohistochemistry (IHC), meanwhile, has seen significant adoption for biomarker detection in oncology, with antibody-based staining systems being integrated into lab automation chains for consistency and scalability.

Moreover, the advent of digital pathology is transforming slide-based diagnostics from analog to image-centric platforms. Whole-slide imaging (WSI) devices convert traditional glass slides into high-resolution digital formats, which are then analyzed via AI-powered software for cell morphology, tumor grading, and anomaly detection. This digital transition is enabling remote collaboration between pathologists, reducing inter-observer variability, and supporting telepathology for underserved and rural regions. As hospitals consolidate into integrated healthcare systems, the demand for pathology device interoperability and centralized diagnostics continues to rise.

What Technology Innovations Are Disrupting Traditional Pathology Workflows?

Digital transformation is redefining the pathology device landscape by integrating imaging, analytics, and cloud infrastructure into conventional workflows. Whole-slide scanners, capable of capturing images at 40x magnification, are increasingly equipped with high-speed autofocus, z-stacking for depth resolution, and batch scanning capabilities for large sample volumes. These devices are complemented by AI/ML algorithms that assist in quantifying tissue features, flagging potential abnormalities, and generating automated diagnostic suggestions-streamlining the pathologist’s decision-making process.

Automation is another key disruptor. From robotic arms used in sample accessioning to smart staining platforms that auto-select reagents and protocols, pathology labs are minimizing manual intervention to reduce turnaround time and error rates. Modular lab automation systems now link sample tracking, barcode readers, liquid handlers, and slide cover-slippers into a seamless diagnostic pipeline, allowing laboratories to achieve faster throughput without compromising diagnostic accuracy. Integration with Laboratory Information Systems (LIS) further ensures real-time tracking, compliance, and reporting efficiency.

Additionally, the rise of companion diagnostics is influencing device development. Pharmaceutical companies and diagnostics manufacturers are collaborating to build pathology platforms that support tissue-based biomarker validation, enabling targeted therapies and personalized oncology treatments. Multiplex IHC and in situ hybridization (ISH) tools are helping laboratories detect multiple biomarkers on a single slide, increasing diagnostic yield while conserving tissue samples. These technologies are also being validated for regulatory compliance under FDA and CE marking frameworks, making them viable for clinical deployment worldwide.

Which End-Use Settings and Regional Markets Are Driving Demand for Pathology Devices?

Hospitals, diagnostic reference laboratories, academic medical centers, and cancer research institutions represent the primary end-users of pathology devices. Large hospital chains are rapidly adopting automated pathology platforms to accommodate growing biopsy volumes, shorten reporting timelines, and optimize pathology manpower. Centralized labs that process tests for multiple healthcare providers are increasingly investing in robotic and digital pathology solutions to boost efficiency and enable remote consultations.

Academic institutions and cancer centers play a critical role in the early adoption of next-generation devices, particularly those involving AI interpretation and multiplex immunohistochemistry. These centers often serve as validation hubs for emerging technologies and contribute to the evidence base required for clinical and regulatory approvals. Additionally, pharmaceutical R&D and contract research organizations (CROs) are adopting digital pathology platforms for biomarker screening and drug efficacy trials-creating a growing non-clinical market for pathology devices.

Regionally, North America and Western Europe remain dominant due to advanced healthcare infrastructure, high biopsy volumes, and supportive reimbursement for pathology-based diagnostics. The U.S., in particular, is witnessing consolidation of pathology labs and strong uptake of digital pathology due to favorable CMS policies and FDA's digital imaging guidelines. Meanwhile, Asia-Pacific-led by China, India, and South Korea-is experiencing rapid growth in pathology infrastructure as cancer screening programs expand and public-private diagnostic chains scale up operations. Latin America and the Middle East are emerging markets where investments in tertiary care and cancer diagnosis are opening up new pathways for device adoption.

What Factors Are Driving the Growth of the Global Pathology Devices Market?

The growth in the global pathology devices market is driven by the increasing prevalence of chronic and oncological diseases, demand for early and accurate diagnostics, advancements in digital pathology and lab automation, and the global push toward personalized medicine. With rising cancer incidence, aging populations, and greater awareness about preventive health, there is growing pressure on diagnostic systems to deliver fast, reproducible, and actionable results-propelling the demand for advanced pathology devices.

Healthcare systems worldwide are adopting centralized and digitized pathology platforms to address shortages of trained pathologists, reduce sample-to-report time, and improve diagnostic quality. In parallel, the integration of pathology with molecular diagnostics and AI analytics is enabling clinicians to extract deeper insights from tissue samples, paving the way for personalized therapy plans. These factors are particularly relevant in oncology, where treatment efficacy often depends on precise tumor classification and biomarker status.

Furthermore, strong investments from medical device firms, venture capitalists, and healthcare IT companies are accelerating innovation and commercialization. Collaborations between diagnostic labs, tech companies, and pharma players are resulting in co-developed solutions tailored for next-generation healthcare. Regulatory advancements, such as digital pathology device approvals and flexible clinical trial requirements, are further removing entry barriers. As digital and precision medicine converge, pathology devices are set to become indispensable to modern diagnostics, driving strong and sustained global market expansion.

SCOPE OF STUDY:

The report analyzes the Pathology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology, Other Technologies); Application (Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application, Other Applications); End-User (Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • 3DHISTECH
  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter (Danaher)
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories
  • CellaVision
  • ContextVision
  • Danaher Corporation
  • Epredia (3DHISTECH)
  • F. Hoffmann-La Roche AG
  • Hamamatsu Photonics
  • Hamamatsu Photonics
  • Leica Biosystems (Danaher)
  • Mikroscan Technologies
  • Olympus Corporation
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • PHC Holdings / Sakura Finetek
  • Philips (Digital Pathology)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Pathology Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Cancer Burden Throws the Spotlight on Advanced Pathology Diagnostic Equipment
    • Automation and Digital Pathology Trends Drive Demand for High-Throughput Devices
    • Integration of Artificial Intelligence in Histopathology Spurs Workflow Efficiency and Accuracy
    • Expansion of Precision Medicine and Molecular Diagnostics Strengthens Business Case for Pathology Platforms
    • Increased Adoption of Digital Slide Scanners and Image Analysis Systems Propels Market Growth
    • Growth in Biopsy Testing and Early Disease Detection Accelerates Use of Specialized Pathology Instruments
    • Integration of LIS and EMR Systems Enhances Data Interoperability for Pathology Labs
    • Global Shortage of Pathologists Promotes Use of AI-Driven Diagnostic Devices
    • Demand for Remote Pathology and Telemedicine Platforms Expands Use of Digital Diagnostic Equipment
    • Government Funding for Cancer Screening and Laboratory Modernization Supports Market Penetration
    • Regulatory Approvals for AI-Based Diagnostic Algorithms Spur Commercialization of Smart Devices
    • Advancements in Multi-Modality Imaging and Staining Technologies Enhance Device Functionality
    • Rising Geriatric Population Drives Screening Volume for Age-Linked Diseases and Tumors
    • Focus on Lab Efficiency and Turnaround Time Reductions Fuels High-Speed Device Adoption
    • Increased Sample Volume in Oncology and Infectious Disease Diagnostics Boosts Equipment Demand
    • Growth in Clinical Research and Biobank Development Expands Pathology Device Applications
    • Emergence of Integrated Pathology Workstations Optimizes End-to-End Diagnostic Workflows
    • Market Consolidation Among Device Manufacturers Spurs Innovation Through Strategic Acquisitions
    • Customization and Scalability Requirements Propel Demand for Modular Pathology Systems
    • Stringent Quality Control and Accreditation Norms Drive Adoption of Standardized Diagnostic Equipment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pathology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pathology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Clinical Chemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Immunoassays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Microbiology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharmaceutical Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Diagnostic Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals & Diagnostic Laboratories End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Forensic Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Forensic Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Forensic Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Pathology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Pathology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Pathology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Pathology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제